COVID-19 antibodies enable tissue-based detection of viral infection
HistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read more
monoclonal antibodies
Sanofi to purchase Kymab and add OX40L monoclonal antibody to its pipeline
Sanofi is set to acquire Cambridge, UK-headquartered Kymab and thereby add KY1005 to its pipeline, a human monoclonal antibody targeting
Read more
Anti-Lamin B1 Antibody
With the anti-lamin B1 mouse specific antibody and the anti-lamin B1 human specific antibody developed by HistoSure, researchers can distinguish
Read more
Anti-Mouse CD45 Antibody
The new Anti-mouse CD45 Antibody from HistoSure is specifically developed for superior results in IHC-P (FFPE) applications. CD45 CD45, also
Read more
Anti-mutated Calreticulin CALR (CAL2) Antibody
This monoclonal anti-mutated Calreticulin CALR (CAL2) antibody recognises all forms of C-terminus mutated CALR. Calreticulin (CALR) mutations Calreticulin (CALR) mutations
Read more
Monoclonal Rat Antibody Against Ki67
The monoclonal rat antibody against Ki67 developed by HistoSure only recognizes mouse Ki67 and shows no cross-reactivity against human Ki67.
Read more
Lilly to supply 300,000 vials of COVID-19 monoclonal antibody to the U.S.
Eli Lilly and Company officially announced on Oct. 28, an initial deal with the U.S. government to supply 300,000 vials
Read more
Lilly’s Mirikizumab shows reduction of Intestinal Inflammation in Crohn’s Disease
Eli Lilly and Company revealed on Monday, new efficiency and safety results from the Phase 2 SERENITY trial assessing Mirikizumab
Read more
Enzolytics and BioClonetics intent to merge sends stock parabolic
Enzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of
Read more
Donald Trump treated with experimental Monoclonal Antibody cocktail
United States President Donald Trump has been administered with an intravenous dose of Regeneron Pharmaceuticals experimental COVID-19 treatment REGN-COV2, a
Read more